189 related articles for article (PubMed ID: 23196585)
1. [Myotonic dystrophy type 2].
Kimura T
Rinsho Shinkeigaku; 2012; 52(11):1267-9. PubMed ID: 23196585
[TBL] [Abstract][Full Text] [Related]
2. [Myotonic dystrophy type 2].
Kimura T; Saito T
Brain Nerve; 2011 Nov; 63(11):1151-60. PubMed ID: 22068467
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
6. Myotonic dystrophy type 2 and related myotonic disorders.
Meola G; Moxley RT
J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
[TBL] [Abstract][Full Text] [Related]
8. The expanding clinical and genetic spectrum of the myotonic dystrophies.
Ricker K
Acta Neurol Belg; 2000 Sep; 100(3):151-5. PubMed ID: 11098287
[TBL] [Abstract][Full Text] [Related]
9. Myotonic dystrophy types 1 and 2.
Ashizawa T; Sarkar PS
Handb Clin Neurol; 2011; 101():193-237. PubMed ID: 21496635
[TBL] [Abstract][Full Text] [Related]
10. Myotonic dystrophy type 2.
Finsterer J
Eur J Neurol; 2002 Sep; 9(5):441-7. PubMed ID: 12220374
[TBL] [Abstract][Full Text] [Related]
11. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
Finsterer J; Rudnik-Schöneborn S
Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
[TBL] [Abstract][Full Text] [Related]
12. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2).
Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic heterogeneity in myotonic dystrophies.
Meola G
Muscle Nerve; 2000 Dec; 23(12):1789-99. PubMed ID: 11102902
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patients.
Sulek A; Lusakowska A; Krysa W; Rajkiewicz M; Kaminska A; Nojszewska M; Kostera-Pruszczyk A; Zdzienicka E; Kubalska J; Rakowicz M; Szirkowiec W; Kwiecinski H; Zaremba J
Neurol Neurochir Pol; 2018; 52(6):736-742. PubMed ID: 29588063
[TBL] [Abstract][Full Text] [Related]
15. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
16. Optimization PCR for Detection CTG/CCTG-Repeat Expansions in the Diagnosis of Myotonic Dystrophies.
Meng YX; Shen HR; Zhao Z; Bing Q; Li N; Hu J
Ann Clin Lab Sci; 2015; 45(5):502-7. PubMed ID: 26586700
[TBL] [Abstract][Full Text] [Related]
17. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
Wenninger S; Stahl K; Montagnese F; Schoser B
Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in myotonic dystrophy type 2.
Ulane CM; Teed S; Sampson J
Curr Neurol Neurosci Rep; 2014 Feb; 14(2):429. PubMed ID: 24435591
[TBL] [Abstract][Full Text] [Related]
19. Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
Dabby R; Sadeh M; Herman O; Leibou L; Kremer E; Mordechai S; Watemberg N; Frand J
Isr Med Assoc J; 2011 Dec; 13(12):745-7. PubMed ID: 22332444
[TBL] [Abstract][Full Text] [Related]
20. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
Sansone VA; Brigonzi E; Schoser B; Villani S; Gaeta M; De Ambroggi G; Bandera F; De Ambroggi L; Meola G
Int J Cardiol; 2013 Sep; 168(2):1147-53. PubMed ID: 23266299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
